Alpha Cognition (ACOG) Capital Expenditures (2025)
Alpha Cognition (ACOG) posted quarterly Capital Expenditures of $147523.0 for Q4 2025, up 98.33% quarter-over-quarter from $74381.0 in Q3 2025.
Alpha Cognition (ACOG) Capital Expenditures (2025) Analysis & Trends
Alpha Cognition's Capital Expenditures history runs 1 years deep, the most recent figure standing at $147523.0 for Q4 2025.
- In Q4 2025, Capital Expenditures changed N/A year-over-year to $147523.0; the TTM figure through Dec 2025 stood at $293489.0 (changed N/A YoY), while the FY2025 annual figure was $293489.0, up 999.17% from the prior year.
- Capital Expenditures for Q4 2025 stood at $147523.0, up from $74381.0 in the prior quarter.
- The five-year high for Capital Expenditures was $147523.0 in Q4 2025, with the low at $8315.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 251.02 Mn |
| 10 | Alpha Cognition | 207.07 Mn | 165.63 Mn | 5.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 147,523.00 |
| Dec 31, 2025 | 147,523.00 |
| Sep 30, 2025 | 74,381.00 |
| Sep 30, 2025 | 74,381.00 |
| Jun 30, 2025 | 8,315.00 |
| Jun 30, 2025 | 8,315.00 |
| Mar 31, 2025 | 63,270.00 |
| Mar 31, 2025 | 63,270.00 |